دورية أكاديمية
أعرض في EDS

Berberine for Adjunct/Alternative Treatment of Dyslipidemia: A Literature Review.

التفاصيل البيبلوغرافية
العنوان: Berberine for Adjunct/Alternative Treatment of Dyslipidemia: A Literature Review.
المؤلفون: Evbayekha EO; Internal Medicine, St. Luke's Hospital, Chesterfield, USA., Nwachukwu EU; Family Medicine, University of Uyo Teaching Hospital, Uyo, NGA., Nikravesh E; Family Medicine, Guilan University of Medical Sciences, Rasht, IRN., Rosas V; Psychiatry, MCR Behavioral Health Services, Temecula, USA., Onuegbu CA; Internal Medicine, Montefiore Medical Center, Bronx, USA., Egwuonwu OF; Family Medicine, University of Nigeria Teaching Hospital, Enugu, NGA., Eguagie O; Medicine, St. George's University, True Blue, GRD., Chioma OE; Surgery, Federal Medical Center Keffi, Keffi, NGA., Agho AV; Internal Medicine, University of Benin, Benin, NGA., Samuels KA; Internal Medicine, Escuela Latinoamericana de Medicina, Havana, CUB., Willie A; Emergency Medicine, Igbinedion University Okada, Benin, NGA., Nwafor JN; Internal Medicine, University of the District of Columbia, Silver Spring, USA., Esene-Akhideno LN; School of Medicine, American University of St. Vincent, Kingstown, VCT., Adigun AO; Infectious Diseases, University of Louisville, Louisville, USA.
المصدر: Cureus [Cureus] 2023 May 20; Vol. 15 (5), pp. e39261. Date of Electronic Publication: 2023 May 20 (Print Publication: 2023).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Berberine (BBR) is an ancient plant popular in China and is used to treat dyslipidemia, among other cardiovascular and metabolic-related diseases. BBR has historically been regarded as having multiple benefits, with a few clinical trials indicating this fact. We searched PubMed, Embase, and Google Scholar with the following keywords: Berberidaceae, berberine, Berberis spp., dyslipidemia, atherosclerosis, and inflammation. We synthesized the information within the literature to provide an updated review of BBR, its potential, and its applicability in real-world medicine in the future. This review sought to evaluate the literature and advancement in BBR's efficacy regarding dyslipidemia, inflammation, and atherosclerosis.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Evbayekha et al.)
References: Cureus. 2022 Jan 31;14(1):e21781. (PMID: 35251851)
Nat Med. 2011 Nov 07;17(11):1410-22. (PMID: 22064431)
Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2170-6. (PMID: 16100034)
Cureus. 2022 Dec 29;14(12):e33111. (PMID: 36721619)
Front Pharmacol. 2021 Apr 26;12:653887. (PMID: 33981233)
Metabolism. 2014 Sep;63(9):1167-77. (PMID: 25002181)
Cureus. 2021 Feb 7;13(2):e13186. (PMID: 33717730)
Evid Based Complement Alternat Med. 2014;2014:289264. (PMID: 24669227)
Atherosclerosis. 2014 Aug;235(2):644-8. (PMID: 24973595)
Endocr Rev. 2022 Jul 13;43(4):611-653. (PMID: 34676866)
J Biol Chem. 2009 Oct 16;284(42):28885-95. (PMID: 19687008)
Pharmacogn Mag. 2017 Oct-Dec;13(52):677-682. (PMID: 29200733)
Eur J Pharmacol. 2015 Aug 15;761:288-97. (PMID: 26092760)
Front Med (Lausanne). 2022 Apr 28;9:886996. (PMID: 35572960)
J Ethnopharmacol. 2015 Feb 23;161:69-81. (PMID: 25498346)
Pol Merkur Lekarski. 2017 Mar 21;42(249):125-128. (PMID: 28333905)
J Transl Med. 2015 Mar 15;13:92. (PMID: 25884210)
Biochem Biophys Res Commun. 2016 Apr 15;472(4):603-9. (PMID: 26970305)
Eur J Pharmacol. 2014 Oct 5;740:584-95. (PMID: 24973693)
Oncotarget. 2017 Sep 11;9(11):10135-10146. (PMID: 29515798)
Molecules. 2021 Aug 05;26(16):. (PMID: 34443321)
J Transl Med. 2015 Aug 27;13:278. (PMID: 26310319)
Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E812-9. (PMID: 19176354)
Cell Metab. 2012 Apr 4;15(4):545-53. (PMID: 22445600)
Med Sci Monit. 2019 Jan 04;25:87-97. (PMID: 30606998)
Expert Opin Biol Ther. 2012 Aug;12(8):1113-24. (PMID: 22780092)
Acta Pharmacol Sin. 2017 Feb;38(2):157-167. (PMID: 27917872)
Phytomedicine. 2018 Nov 15;50:25-34. (PMID: 30466986)
Front Pharmacol. 2021 Jul 09;12:709629. (PMID: 34305616)
Anal Bioanal Chem. 2019 May;411(14):3191-3207. (PMID: 30972469)
Cureus. 2021 Jun 20;13(6):e15770. (PMID: 34295580)
فهرسة مساهمة: Keywords: atherosclerosis; berberidaceae; berberine; berberis spp; dyslipidemia; inflammation
تواريخ الأحداث: Date Created: 20230622 Latest Revision: 20230701
رمز التحديث: 20230701
مُعرف محوري في PubMed: PMC10279928
DOI: 10.7759/cureus.39261
PMID: 37346213
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.39261